Publication Update - New Insights into SARS-CoV-2 Inhibition

The Future Medicines Institute is pleased to highlight a new publication in ACS Medicinal Chemistry Letters: “Identification and Exploration of a Series of SARS-Cov-2 MPro Cyano-Based Inhibitors Revealing Ortho-Substitution Effects within the P3 Biphenyl Group.”

Congratulations to all those in our team who were involved in this work, in particular FMI Research Fellow Emma Clyde-Allen and Academic Lead Rich Williams!

Please get in touch for any queries regarding this study or if you want to leverage the expertise of our Chemical Biology team.

🔗 Read the paper: https://lnkd.in/e3d_EDsZ